Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

District of Columbia

CNS trials open to children and teens in District of Columbia

10 CNS studies open to children and teens are recruiting participants at sites in 1 city across District of Columbia as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every District of Columbia city with a recruiting study

By research area: Migraine (5), Depression (3), ADHD (1), Schizophrenia (1).

Washington D.C. (10).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in District of Columbia

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

    • No phase
    • Ages 8 to 16
    • All sexes
    Sponsor
    Children's National Research Institute
    Recruiting in
    Washington D.C.
    Registry record
    NCT05099874 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in District of Columbia on ClinicalTrials.gov.

Depression: recently updated in District of Columbia

  1. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Washington D.C.
    Registry record
    NCT07227454 · updated
  2. Does Social Media Impact Adolescent Mental Health?

    • No phase
    • Ages 10 to 14
    • All sexes
    Sponsor
    Georgetown University
    Recruiting in
    Washington D.C.
    Registry record
    NCT06049888 · updated
  3. Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes

    • No phase
    • Ages 13 to 17
    • All sexes
    Sponsor
    Children's National Research Institute
    Recruiting in
    Washington D.C.
    Registry record
    NCT06618027 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in District of Columbia on ClinicalTrials.gov.

Migraine: recently updated in District of Columbia

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Washington D.C.
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Washington D.C.
    Registry record
    NCT04743141 · updated
  3. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Washington D.C.
    Registry record
    NCT05156398 · updated
  4. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    • Phase 1
    • Ages 6 to 11
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Washington D.C.
    Registry record
    NCT06995729 · updated
  5. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Washington D.C.
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in District of Columbia on ClinicalTrials.gov.

Schizophrenia: recently updated in District of Columbia

  1. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Alkermes, Inc.
    Recruiting in
    Washington D.C.
    Registry record
    NCT05303064 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in District of Columbia on ClinicalTrials.gov.

Ask about studies in District of Columbia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call